Does off-the-shelf personalized immunotherapy make a bargainvs. their peers in the industry as they claim? And a take-out target?
Whe know why the SP is under pressure. About 43 million units @ 10 cents that consist of a common share + warrant with $0.14 strike price. That part isn't complicated.
These shares were retricted from trading until July 20, 2018. Even selling a 10 cents the people that bought those units still have a warrent that could make them money.
It is annoying for those of us that have bought and held shares at a higher price. But if their technology is all that they claim than the availablity of these cheap shares is an opportunity rather than a problem.